Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$10.72 USD
-0.03 (-0.28%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $10.69 -0.03 (-0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
NA
Time: -- |
6/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Perspective Therapeutics, Inc. (CATX) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 33.33%. Look out for CATX's next earnings release expected on . For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 47.5%.
Earnings History
Price & Consensus
Zacks News for CATX
Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline
CATX: What are Zacks experts saying now?
Zacks Private Portfolio Services